Grace Therapeutics, Inc. (GRCE)
$2.18-0.91%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $35M
- Avg volume
- 303.3K
- Beta
- 0.37
- P/E (TTM)
- -1.74
- Short % float
- 11.69%
- Days to cover
- 5.7
- SI change
- -2.6%
- 1W
- +0.93%
- 1M
- -6.44%
- 3M
- -0.91%
- YTD
- -40.44%
- vs SPY 1W
- +2.12%
- vs SPY 1M
- -9.76%
- vs SPY 3M
- -3.30%
- vs SPY YTD
- -52.19%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- QUCYBUYMainz Biomed N.V.CRISISQ -20$1.31+0.77%
- IDYABUYIDEAYA Biosciences, Inc.BULLQ 26$40.04+0.93%
- TRIBSELLTrinity Biotech plcCRISISQ 3$10.33-2.55%
- BTAISELLBioXcel Therapeutics, Inc.CRISISQ -11$0.76-5.00%
- QDELSELLQuidelOrtho CorporationCRISISQ 8$14.49-1.70%
- VRDNBUYViridian Therapeutics, Inc.RECOVERYQ -2$24.02-1.11%
- MDWDSELLMediWound Ltd.RECOVERYQ -5$13.00-1.59%
- OTRKQBUYOntrak, Inc.RECOVERYQ -8$0.00
- SPRYBUYARS Pharmaceuticals, Inc.CRISISQ -2$5.35-2.90%
- OCGNBUYOcugen, Inc.RECOVERYQ -6$1.36-2.16%
- PROKSELLProKidney Corp.RECOVERYQ 0$1.61+0.00%
- CAMPBUYCAMP4 Therapeutics CorporationCRISISQ -5$4.32-3.57%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 2
- VALUE
- 0
- GROWTH
- 43
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-21.5%
REV YoY-
ROE-4.9%
EPS YoY-
ROA-42.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-1.74
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B0.78
P/FCF-
EV/EBITDA-0.85
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO11.47
ND/EBITDA-
BETA0.37
NET INCOME (TTM) < 0
